UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Using human induced pluripotent stem cells (hiPSCs), researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California, San Diego have discovered that neurons from patients with schizophrenia secrete higher amounts of three neurotransmitters broadly implicated in a range of psychiatric disorders.
The American Society of Health-System Pharmacists (ASHP) has named Charles E. Daniels, PhD, FASHP, as the recipient of the 2014 John W. Webb Lecture Award. The Webb Award honors health-system pharmacy practitioners or educators who stand apart because of their extraordinary dedication to fostering excellence in pharmacy management and leadership.
Effective July 1, 2014, James H. McKerrow, MD, PhD, will become the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. McKerrow will join UC San Diego from UC San Francisco, where he served as professor of pathology and director of the Center for Discovery and Innovation in Parasitic Diseases.
Researchers at the University of California, San Diego School of Medicine have discovered a widely distributed group of marine bacteria that produce compounds nearly identical to toxic man-made fire retardants.
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, have identified the genes encoding a molecule that famously defines Group A Streptococcus (strep), a pathogenic bacterial species responsible for more than 700 million infections worldwide each year.
L.S. “Sam” Skaggs, whose enduring support of pharmacy education and research helped fuel the growth and development of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, died Thursday at the age of 89 of causes related to age.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
